Stay updated with breaking news from Gerhard Hindricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The emergence of new medicinal treatments may have changed the risk-benefit ratio of routine ICD implantation in patients with a severely abnormal LVEF after a heart attack.
The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.
Although artificial intelligence is changing the role of the physician, several experts agreed that it is not making cardiologists superfluous.
Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate....
Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure still an adequate therapy for prevention of sudden cardiac death?